Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

A.C.: Yes. You don’t have hair follicles on the back of your hands. The areas that have the best healing are the areas that ...

With $70 million and a phase 2 ready asset in hand, British biotech Elevara Medicines has emerged to try to revolutionize the ...

Arthritis is a widespread condition that leads to pain, stiffness, and inflammation in the joints, often worsening with age.

Overall, the median duration of b/tsDMARD use was 4.3 years, longer in RA (6.3 years) than axSpA (3 years). TNF inhibitors ...

Hand swelling, or oedema, can stem from various causes including heat, high salt intake, exercise, and pregnancy. Underlying ...

A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in an international clinical trial of more than 200 patients worldwide.

Treating rheumatoid arthritis (RA) typically means taking drugs to address the inflammatory process that leads to joint pain in RA. These drugs may be taken by mouth, or by injection or infusion. But ...

A new surgically implanted device the size of a lima bean can help control rheumatoid arthritis that isn't responding to ...

Rheumatoid arthritis is often linked to joint pain and stiffness, but it can also trigger unusual symptoms such as hearing loss, skin rashes, breathing difficulties, and even heart problems.

People with rheumatoid arthritis usually depend on drugs to control pain in their joints. But this summer, the Food and Drug Administration approved a different sort of treatment. It's a device that ...